Relationship of Volume of Lesion to Length of Hospital Stay and Outcome at One Year in Stroke Patients

Abstract

The aim of this study was to investigate the relationship between the volume of lesion (VOL) in patients with stroke and the associated length of hospital stay (LOS), as well as longer-term functional outcome. Computerised tomography (CT) scans were used to measure the volume, region and type of lesion, volume being measured by planimetry. LOS and other patient details were obtained from the Dundee Stroke Database. The total LOS was associated with the VOL on univariate analysis (p=0.004) and after adjustment for the other variables (p-0.006) due to a larger lesion being associated with longer stay in hospital. Patient follow-up confirmed that the VOL was also highly significant when related to functional outcome measures of impairment, disability and handicap at one year, as determined by Orgogozo (p=0.03), Barthel (p<0.01) and Rankin scores (p<0.01) respectively. The VOL is related to the length of stay in hospital and outcome at one year. This is of particular interest with the increasing use of thrombolysis and development of neuroprotectant agents designed to limit VOL.

Keywords

Stroke volume of lesion length of hospital stay predictors outcome

References

Patel

Potter

Perez

Kaira

. The process of rehabilitation and discharge planning in stroke: A controlled comparison between two stroke units. Stroke 1998; 29: 2484–7.

Harvey

R L

Roth

E J

Heinemann

A W

Lovell

L L

McGuire

J R

Diaz

. Stroke rehabilitation: Clinical predictors of resource utilisation. Arch Phys Med Rehabil 1998; 79: 1349–55.

Orgogozo

J M

: Evaluation of treatments in ischaemic stroke patients; in Amery

W K

(ed). Clinical trial methodology of stroke. London, Ballibre Tindall, 1989, pp 35–53.

MaAoney

F I

Barthel

D W

. Functional evaluation: The BarthelIndex. Md State Med J 1965; 14: 61.

Rankin

. Cerebral vascular accidents in patients over the age of 60. Scott Med J 1957; 2: 200–15.

MacWalter

R S

Coid

D R

Fraser

H W

Ersoy

. The Dundee Stroke Register: Experience of the first ten years. Scott Med J 1999; 44: 103–5.

Merrylees

Taylor

T W

Shaw

J W

Fraser

H W

Dutta

Ersoy

MadWalter

R S

. CT brain scans after acute stroke: How far are we from meeting the Scottish Intercollegiate Guidelines Network (SIGN) recommendations? Results from the year prior to guideline publication. Health Bull 1999; 57: 240–4.

Meerwaldt

J D

. Spatial disorientation in right-hemisphere infarction: A study of the speed of recovery. J Neurol Neurosurg Psychiatry 1983; 46: 426–9.

Demeurisse

Capon

Verhas

. Prognostic value of computed tomography in aphasic stroke patients. Eur Neurol 1985; 24: 134–9.

10.

Pantano

Formisano

Ricci

DiPiero

Sabatini

DiPofi

Rossi

Bossao

Lensi

G L

. Motor recovery after stroke. Morphological and functional brain alterations. Brain 1996; 119: 1849–57.

11.

DeFalco

F A

Mastroroberto

Massei

Montanello

Saccaria

SepeVisconti

. Atrial fibrillation and infarct area extent in ischaemic stroke. A clinical and neuroradiological study in 104 patients. Acta Neurol Napoli 1991; 13: 249–54.

12.

Beloosesky

Streifier

J Y

Burstin

Grinblat

. The importance of brain infarct size and location in predicting outcome after stroke. Age Ageing 1995; 24: 515–8.

13.

Bowler

J V

Wade

J P

Jones

B E

Nijran

, Steiner T1 Single-photon emission computed tomography using hexamethylpropyleneamine oxime in the prognosis of acute cerebral infarction. Stroke 1996 27: 82–6.

14.

Mir

C J

Bolster

A A

Tyfier

Murray

Corrigall

R S

Adams

F G

Lees

K R

. Prognostic value of single-photon emission tomography in acute ischaemic stroke. Eur J Nucl Med 1997; 24: 21–6.

15.

Lees

K R

Weir

C J

Gillen

G J

Taylor

A K

Ritchie

. Comparison of mean cerebral transit time and single-photon emission tomography for estimation of stroke outcome. Eur J Nucl Med 1997; 22: 1261–7.

16.

Woo

Kay

Yuen

Y K

Nicholls

M G

. Factors Influencing long-term survival and disability among three month stroke survivors. Neuroepidemiology 1992; 11: 143–50.

17.

Saunders

D E

Clifton

A G

Brown

M M

. Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction. Stroke 1995; 26: 2272–6.

18.

Mintyli

Pohjasvaara

Vataja

Salonen

Aronen

H J

Standerskj6ld-Nordenstam

C G

Kaste

Erkinjuntii

. MRI pontine hypersensitivity after supratentorial ischaemic stroke relates to poor clinical outcome. Stroke 2000; 31: 695–700.

19.

Wardlaw

J I V I

Marshall

Wild

Dennis

M S

Cannon

Lewis

S C

. Studies of acute ischaemic stroke with proton magnetic resonance spectroscopy: Relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke 1998; 29: 1618–24.

20.

Pereira

A C

Saunders

D E

Doyle

V L

Bland

J I V I

Howe

F A

Griffiths

J R

Brown

M M

. Measurement of initial N-acetyl aspartate concentration by magnetic resonance spectroscopy and initial infarct volume bu MRI predicts outcome in patients with middle cerebral artery territory infarction. Stroke 1999; 30: 1577–82.

21.

Barber

P A

Darby

D G

Desmond

P M

Yang

Gerraty

R P

Jolley

Donnan

G A

Tress

B M

Davis

S. M.

Prediction of stroke outcome with echoplanar perfusion and diffusion weighted MRI. Neurology 1998; 51: 418–26.

22.

Cunningham

R T

Young

I S

Winder

O'Kane

M J

McKinstry

Johnston

C F

Dolan

O M

Hawkins

S A

Buchanan

K I D

. Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 1991; 21: 497–500.

23.

Wang

Yang

. Neuron-specific enolase in patients with acute ischaemic stroke and related dementia. Chin Med J Engi 1995; 108: 221–3.

24.

Cunningham

R T

Watt

Winder

McKinstry

Lawson

J T

Johnston

C F

Hawkins

S A

Buchanan

K I D

. Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest 1996; 26: 298–303.

25.

Missler

Wiesmann

Friedrich

Kaps

. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischaemic stroke. Stroke 1997; 28: 1956–60.

26.

Castillo

Davalos

Naveiro

Noya

. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischaemic stroke. Stroke 1996; 27: 1060–5.

27.

Bitsch

Klene

Murtada

Prange

Rieckmann

. A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 1998; 29: 2129–35.

28.

Spranger

Krempien

Schwab

Donneberg

Hacke

. Superoxide dismutase activity in serum of patients with acute cerebral ischaemic injury. Correlation with clinical course and infarct size. Stroke 1997; 28: 2425–8.

29.

Tarkowski

Rosengren

Blomstrand

Wikkelso

Jensen

Ekholm

Tarkowski

. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995; 26: 1393–8.

30.

Hay

Royds

J A

Davies-Jones

G A

Lewtas

N A

Timperley

W R

Taylor

C B

. Cerebrospinal fluid enolase in stroke. J Neurol Neurosurg Psychiatry 1984; 47: 724–9.

31.

Jongbioed

. Prediction of function after stroke: A critical review. Stroke 1986; 17: 765–76.

32.

Granger

C V

Hamilton

B B

. Measurement of stroke rehabilitation outcome in the 1980s. Stroke 1990; 21 (9 Suppl): 1146–7.

33.

Feigenson

J S

McDowell

F H

Meese

McCarthy

M L

Greenberg

S I D

. Factors influencing outcome and length of stay in a stroke rehabilitation unit. Stroke 1977; 8: 651–6.

34.

Alexander

M P

. Stroke rehabilitation outcome. A potential use of predictive variables to estWish level of care. Stroke 1994; 25: 128–34.

35.

Falconer

J A

Naughton

B J

Strasser

D C

Sinacore

J M

. Stroke inpatient rehabilitation:- a comparison across age groups. J Am Geriatr Soc 1994; 42: 39–44.

36.

Njoistad

Amesen

Lund-Larsen

P G

. Body height, cardiovascular risk factors, and risk of stroke in middle-ages men and women. A 14-year follow up of the Finnmark Study. Circulation 1996; 94: 2877–82.

37.

Dandapani

B K

Suzuki

Kelley

R E

Reyes-Giesias

Duncan

R C

. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995; 26: 21–4.

38.

Slivka

A P

. Hypertension and hyperglycaemia in experimental stroke. Brain Res 1991; 562: 66–70.

39.

Woo

Chan

Y W

Y L

Huang

C Y

. Admission glucose level in relation to mortality and morbidity outcome in 252 stroke patients. Stroke 1988; 19: 185–9.

40.

Gray

C S

Taylor

French

J M

Alberti

K G

Venables

G S

James

O F

Shaw

D A

Cartlidge

N E

Bates

The prognostic value of stress hyperglycaemia and previously unrecognized diabetes in acute stroke. Diabet Med 1987; 4: 237–40.

41.

Woo

Lam

C W

Kay

Wong

A H

Teoh

Nicholls

M G

. The influence of hyperglycaemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol 1990; 47: l 174–7.

42.

Toni

Sacchetti

I V I L

Argentino

Gentile

Cavalletti

Frontoni

Fieschi

. Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? J Neurol 1992; 239: 382–6.

43.

Sprafka

J I V I

Vimig

B A

Shahar

McGovern

P G

. Trends in diabetes prevalence among stroke patients and the effect of diabetes on stroke survival: The Minnesota Heart Survey. Diabet Med 1994; 11: 678–84.

44.

Toni

DeMichele

Fiorelli

Bastianello

Camerlingo

Sacchetti

M L

Argentino

Fieschi

. Influence of hyperglycaemia on infarct size and clinical outcome of acute ischaemic stroke patients with intracranial arterial occlusion. J Neurol Sci 1994; 123: 12933.

45.

DeFalco

F A

SepeVisconti

Fucci

Caruso

. Correlation between hyperglycaemia and cerebral infarct size in patients with stroke. A clinical and X-ray computed tomography study in 104 patients. Schweis Arch Neurol Psychiatr 1993; 144: 233–9.